Subscribe To
FAMDF / Futura Medical primed for key year, says broker
FAMDF News
By Proactive Investors
November 2, 2023
Futura Medical wins new product award from Boots
Futura Medical's Eroxon erectile dysfunction treatment won the "New Product of the Year, Healthcare" category at the Boots Supplier Awards 2023 follo more_horizontal
By Proactive Investors
October 25, 2023
Futura Medical receives OTC sign-off in Mexico for ED gel
Futura Medical PLC (AIM:FUM, OTC:FAMDF), a pharmaceutical company specialising in innovative sexual health products, has announced OTC Marketing Autho more_horizontal
By Proactive Investors
October 19, 2023
Futura Medical ED drug roll continues apace
The roll-out of Futura Medical PLC (AIM:FUM, OTC:FAMDF)'s breakthrough erectile dysfunction gel continues apace with sales starting in the company's more_horizontal
By Proactive Investors
October 2, 2023
Futura Medical shares up on patent news - interesting at these levels, says bank
Futura Medical PLC (AIM:FUM, OTC:FAMDF), a pharmaceutical company specialising in sexual health products, has witnessed a 3% increase in its share pri more_horizontal
By Proactive Investors
October 2, 2023
Futura Medical secures patent protection for ED gel out to 2040
Futura Medical PLC (AIM:FUM, OTC:FAMDF), the drug developer specialising in sexual health products, has secured a significant win with the European Pa more_horizontal
By Proactive Investors
September 22, 2023
Futura Medical CEO James Barder discusses FDA approval, market share gains, and plans for Eroxon
In an exclusive with Proactive, James Barder, CEO of Futura Medical PLC (AIM:FUM, OTC:FAMDF), discusses the company's remarkable first half of the yea more_horizontal
By Proactive Investors
September 18, 2023
Futura Medical: Pieces of the jigsaw falling into place, says investment bank
The past year has seen the pieces of the puzzle fall neatly into place for UK-based Futura Medical PLC (AIM:FUM, OTC:FAMDF), according to boutique inv more_horizontal
By Proactive Investors
September 18, 2023
Futura Medical targets profitability as it sees early commercial traction for ED gel
Futura Medical PLC said it expects to be in a break-even position next year as the commercial traction grows around its erectile dysfunction gel Ero more_horizontal